miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
// Jun Lu 1, * , Jin-Huan Wei 1, * , Zi-Hao Feng 1, * , Zhen-Hua Chen 1, * , Yong-Qian Wang 2 , Yong Huang 1 , Yong Fang 1 , Yan-Ping Liang 1 , Jun-Jie Cen 1 , Yi-Hui Pan 1 , Bing Liao 3 , Wen-Fang Chen 3 , Wei Chen 1 , Jun-Hang Luo 1 1 Department of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangdong, China 2 Department of Musculoskeletal Oncology, First Affiliated Hospital, Sun Yat-sen University, Guangdong, China 3 Department of Pathology, First Affiliated Hospital, Sun Yat-sen University, Guangdong, China * These authors contributed equally to this work Correspondence to: Jun-Hang Luo, email: luojunh@mail.sysu.edu.cn Keywords: miR-106b-5p, stemness, Wnt signalling, tumorigenesis, renal cell carcinoma Received: October 29, 2016 Accepted: February 06, 2017 Published: February 21, 2017 ABSTRACT Purpose: To examine the role of miR-106b-5p in regulating the cancer stem-cell-like phenotype in clear cell renal cell carcinomas (ccRCC). Experimental Design: Real-time PCR was performed to evaluate miR-106b-5p levels in ccRCC cell lines and patients specimens. A series of in vivo and in vitro assays were performed to confirm the effect of miR-106b-5p on ccRCC stemness phenotype. Results: ccRCC cells and tissues expressed more miR-106b-5p than normal controls. Gain- and loss-of-function studies demonstrated that overexpression of miR-106b-5p in ccRCC cells increased the spheres formation ability and the proportion of side population cells. Ectopic expression of miR-106b-5p in ccRCC cells increased tumour growth rates and the number of metastatic colonies in the lungs by using an orthotopic kidney cancer model and a tail vein injection model, respectively. Mechanistic studies revealed that, miR-106b-5p has an activating effect on Wnt/β-catenin signalling. miR-106p-5p overexpression simultaneously targets multiple negative regulators of the Wnt/β-catenin pathway, namely, LZTFL1, SFRP1 and DKK2. In addition, we also confirmed that miR-106b-5p and its targets expression correlates with the overall-survival of ccRCC patients from TCGA. Conclusions: These findings suggest that miR-106b-5p mediates the constitutive activation of Wnt/β-catenin signalling, likely serving as a potential therapeutic target for ccRCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer
Peng, Y., Zhang, X., Feng, X., Fan, X., & Jin, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.12923 · Cited by 149 · cited 1×
“It has been found that different miRNAs modulate the Wnt signalling in human malignancy tumors [14].”
BackgroundWnt Signaling in Renal Cell Carcinoma
Xu, Q., Krause, M., Samoylenko, A., & Vainio, S. (2016) · Cancers · doi:10.3390/cancers8060057 · Cited by 99
MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes
Liu, F., Gong, J., Huang, W., Wang, Z., Wang, M., Yang, J., Wu, C., Wu, Z., & Han, B. (2014) · Oncogene · doi:10.1038/onc.2013.428 · Cited by 86
Kruck, S., Eyrich, C., Scharpf, M., Sievert, K.-D., Fend, F., Stenzl, A., & Bedke, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610944 · Cited by 70
Cited by
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
“The vast majority of patients with STK11 mutations were categorized into another subgroup in which well-documented cancer-associated miRNAs such as miR-106b-5p, miR-20a-5p, and miR-17-5p were highly expressed (Lu et al., 2017; Shi et al., 2018).”
BackgroundGruzdev, S. K., Yakovlev, A. A., Druzhkova, T. A., Guekht, A. B., & Gulyaeva, N. V. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00684-6 · Cited by 75
The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism
Yi, Y., Liu, Y., Wu, W., Wu, K., & Zhang, W. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0096-8 · Cited by 23
MicroRNA-106b-5p promotes hepatocellular carcinoma development via modulating FOG2
Yu, L.-X., Zhang, B.-L., Yang, M.-Y., Liu, H., Xiao, C.-H., Zhang, S.-G., & Liu, R. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s203382 · Cited by 20
Metadata
- Authors
- Lu, J., Wei, J.-H., Feng, Z.-H., Chen, Z.-H., Wang, Y.-Q., Huang, Y., Fang, Y., Liang, Y.-P., Cen, J.-J., Pan, Y.-H., Liao, B., Chen, W.-F., Chen, W., & Luo, J.-H.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-02-21
- Volume
- 8
- Issue
- 13
- Pages
- 21461-21471
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2589659966
- Cited by
- 51
- References
- 4
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling. https://app.cochat.ai/papers/10.18632/oncotarget.15591
- The paper
- Lu, J., Wei, J.-H., Feng, Z.-H., Chen, Z.-H., Wang, Y.-Q., Huang, Y., Fang, Y., Liang, Y.-P., Cen, J.-J., Pan, Y.-H., Liao, B., Chen, W.-F., Chen, W., & Luo, J.-H. (2017). miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling. Oncotarget. https://doi.org/10.18632/oncotarget.15591
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.